Efraim H. Rosenberg
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers.
Journal: Nature medicine
Published: April 02, 2026
Evaluation of homologous recombination testing in ovarian carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: November 27, 2025
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 20, 2025
Real-world clinical utility of tumor whole-genome sequencing in solid cancers.
Journal: Nature medicine
Published: February 10, 2025
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.
Journal: Breast cancer research : BCR
Published: August 12, 2024
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 05, 2024
RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models.
Journal: NAR cancer
Published: May 21, 2024
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
Journal: ESMO open
Published: September 13, 2023
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
Journal: BMC medicine
Published: July 21, 2023
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: July 17, 2023
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2.
Journal: Human mutation
Published: January 01, 2023
Last Updated: 09/26/2026